The "ALS Better Care Act" seeks to significantly enhance Medicare coverage for individuals diagnosed with amyotrophic lateral sclerosis (ALS). It amends the Social Security Act to include a defined set of ALS-related services as a covered Medicare benefit, effective January 1, 2027. These crucial services, furnished in an outpatient setting by qualified providers, encompass specialized physician and nurse practitioner support, occupational and physical therapy, speech pathology, dietary and respiratory support, registered nurse assistance, and coordination of durable medical equipment. The bill recognizes that current inadequate reimbursement for these services leads to challenges like extended wait times and hinders innovation in ALS care. To address these issues, the legislation establishes a new Medicare payment system for ALS-related services, providing a single payment to qualified providers in addition to other existing reimbursements. The base payment amount starts at $800 in 2027 and will be adjusted annually based on an ALS services market basket percentage increase or recommendations from the Comptroller General. Importantly, the payment system includes adjustments for providers participating in ALS clinical trials to offset increased costs and for new, significant medical services or technologies. Furthermore, the bill mandates that these payments be made without any cost sharing for the covered ALS individual, ensuring greater access to essential care. Beyond direct service coverage, the Act also requires the Secretary of Health and Human Services, through the National Institute of Neurological Disorders and Stroke, to submit a report within 90 days of enactment. This report will identify challenges in the administration and staffing of ALS clinical trials , propose actions to overcome these hurdles, and offer legislative recommendations to improve trial efficiency and success. This provision aims to accelerate research and the development of new treatments for ALS patients.